Literature DB >> 27326319

Malignant biliary obstruction: From palliation to treatment.

Brian R Boulay1, Aleksandr Birg1.   

Abstract

Malignant obstruction of the bile duct from cholangiocarcinoma, pancreatic adenocarcinoma, or other tumors is a common problem which may cause debilitating symptoms and increase the risk of subsequent surgery. The optimal treatment - including the decision whether to treat prior to resection - depends on the type of malignancy, as well as the stage of disease. Preoperative biliary drainage is generally discouraged due to the risk of infectious complications, though some situations may benefit. Patients who require neoadjuvant therapy will require decompression for the prolonged period until attempted surgical cure. For pancreatic cancer patients, self-expanding metallic stents are superior to plastic stents for achieving lasting decompression without stent occlusion. For cholangiocarcinoma patients, treatment with percutaneous methods or nasobiliary drainage may be superior to endoscopic stent placement, with less risk of infectious complications or failure. For patients of either malignancy who have advanced disease with palliative goals only, the choice of stent for endoscopic decompression depends on estimated survival, with plastic stents favored for survival of < 4 mo. New endoscopic techniques may actually extend stent patency and patient survival for these patients by achieving local control of the obstructing tumor. Both photodynamic therapy and radiofrequency ablation may play a role in extending survival of patients with malignant biliary obstruction.

Entities:  

Keywords:  Catheter ablation; Cholangiocarcinoma; Extrahepatic cholestasis; Pancreatic neoplasms; Stents

Year:  2016        PMID: 27326319      PMCID: PMC4909451          DOI: 10.4251/wjgo.v8.i6.498

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  84 in total

1.  Efficacy of Endoscopic Over 3-branched Partial Stent-in-Stent Drainage Using Self-expandable Metallic Stents in Patients With Unresectable Hilar Biliary Carcinoma.

Authors:  Daisuke Uchida; Hironari Kato; Shinichiro Muro; Yasuhiro Noma; Naoki Yamamoto; Shigeru Horiguchi; Ryo Harada; Koichiro Tsutsumi; Hirofumi Kawamoto; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  J Clin Gastroenterol       Date:  2015-07       Impact factor: 3.062

Review 2.  Surgery for pancreatic cancer: recent controversies and current practice.

Authors:  Curtis J Wray; Syed A Ahmad; Jeffrey B Matthews; Andrew M Lowy
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

3.  Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction.

Authors:  Brian R Boulay; Timothy B Gardner; Stuart R Gordon
Journal:  J Clin Gastroenterol       Date:  2010-07       Impact factor: 3.062

4.  Use of expandable metallic biliary stents in resectable pancreatic cancer.

Authors:  Sanjeev M Wasan; William A Ross; Gregg A Staerkel; Jeffrey H Lee
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

5.  Do preoperative biliary stents increase postpancreaticoduodenectomy complications?

Authors:  T A Sohn; C J Yeo; J L Cameron; H A Pitt; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

6.  Delayed pancreaticoduodenectomy for cancer patients with prior ERCP-placed, nonforeshortening, self-expanding metal stents: a positive outcome.

Authors:  Christopher Lawrence; Douglas A Howell; Donald E Conklin; Andreas M Stefan; Ronald F Martin
Journal:  Gastrointest Endosc       Date:  2006-05       Impact factor: 9.427

7.  Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients.

Authors:  Jeffrey H Lee; Somashekar G Krishna; Amanpal Singh; Harshad S Ladha; Rebecca S Slack; Srinivas Ramireddy; Gottumukkala S Raju; Marta Davila; William A Ross
Journal:  Gastrointest Endosc       Date:  2013-04-13       Impact factor: 9.427

8.  Clinical Impact of Percutaneous Transhepatic Insertion of Metal Biliary Endoprostheses for Palliation of Jaundice and Facilitation of Chemotherapy.

Authors:  Shmuel Mahgerefteh; Ayala Hubert; Alex Klimov; Allan I Bloom
Journal:  Am J Clin Oncol       Date:  2015-10       Impact factor: 2.339

Review 9.  Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography.

Authors:  Jin-Young Choi; Myeong-Jin Kim; Jeong Min Lee; Ki Whang Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2008-11       Impact factor: 3.959

10.  Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma.

Authors:  Mi Jin Hong; Young Koog Cheon; Eung Jun Lee; Tae Yoon Lee; Chan Sup Shim
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

View more
  21 in total

1.  Endoluminal Nd:YAG laser application in ex vivo biliary porcine tissue.

Authors:  Roberta Rea; Francesco Maria Di Matteo; Margareth Martino; Monica Pandolfi; Paola Saccomandi; Carla Rabitti; Anna Crescenzi; Guido Costamagna
Journal:  Lasers Med Sci       Date:  2017-06-30       Impact factor: 3.161

2.  Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary Obstruction.

Authors:  Zhongwei Zhao; Jingjing Song; Xiaoxi Fan; Shiji Fang; Minjiang Chen; Weiqian Chen; Fazong Wu; Liyun Zheng; Jianfei Tu; Jiansong Ji
Journal:  J Gastrointest Surg       Date:  2019-02-21       Impact factor: 3.452

3.  A Risk Prediction Model for Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis After Stent Insertion for Malignant Biliary Obstruction: Development and Validation.

Authors:  Zhifeng Fu; Jitao Song; Yilin Pi; Xianxin Sun; Maoning Liu; Zunlong Xiao; Jing Chen
Journal:  Dig Dis Sci       Date:  2022-08-22       Impact factor: 3.487

Review 4.  Biliary Strictures: Etiologies and Medical Management.

Authors:  Terrance Rodrigues; Justin R Boike
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

5.  Gut peptide changes in patients with obstructive jaundice undergoing biliary drainage: A prospective case control study.

Authors:  Tajana Pavić; Stipe Pelajić; Nina Blažević; Dominik Kralj; Milan Milošević; Ivana Mikolasevic; Ivan Lerotic; Davor Hrabar
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

6.  Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with 125I seeds intracavitary irradiation.

Authors:  X Hu; Q Pang; H Liu; Z Qian; H Jin; L Zhou; Y Wang; Z Man; Z Li; S Yang
Journal:  Clin Transl Oncol       Date:  2018-10-27       Impact factor: 3.405

7.  Stent insertion for inoperable hilar cholangiocarcinoma: Comparison of radioactive and normal stenting.

Authors:  Jia Lin; An-Le Wu; Fei Teng; Yu-Tao Xian; Xin-Jian Xu
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.889

8.  Palliative endoscopic retrograde biliary drainage for malignant biliary obstruction in Korea: A nationwide assessment.

Authors:  Dong Kee Jang; Jungmee Kim; Seung Bae Yoon; Won Jae Yoon; Jung-Wook Kim; Tae Hee Lee; Jae-Young Jang; Chang Nyol Paik; Jun Kyu Lee
Journal:  Saudi J Gastroenterol       Date:  2021 May-Jun       Impact factor: 2.485

Review 9.  Interventional Treatment for Cholangiocarcinoma.

Authors:  Hang Li; Li Chen; Guang-Yu Zhu; Xijuan Yao; Rui Dong; Jin-He Guo
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

10.  Antireflux Metal Stent for Initial Treatment of Malignant Distal Biliary Obstruction.

Authors:  Shinichi Morita; Yasuaki Arai; Shunsuke Sugawara; Miyuki Sone; Yasunari Sakamoto; Takuji Okusaka; Shigetaka Yoshinaga; Yutaka Saito; Shuji Terai
Journal:  Gastroenterol Res Pract       Date:  2018-01-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.